Skip to main content
Government of Quebec
Institut national de santé publique du Québec
Français
FR
Home
Navigation principale
The Institute
The Institute
About us
About us
Products and services offered
Back
Contact us
Contact us
Workplaces
Back
Exit
Back
Expertise
Expertise
Information management and analysis
Information management and analysis
Deprivation
Deprivation
Indices of multiple and multidimensional deprivation
Material and Social Deprivation Index
Back
Health of linguistic communities
Health of linguistic communities
Health Profile of Linguistic Communities in Québec
Back
Back
Individual and community development
Individual and community development
Perinatal and early childhood
Perinatal and early childhood
From Tiny Tot to Toddler
Back
Back
Lifestyles and prevention of chronic illnesses
Lifestyles and prevention of chronic illnesses
Healthy eating and active lifestyle
Healthy eating and active lifestyle
Health-promoting environments
TOPO
Back
Psychoactive substances, tobacco and gambling
Psychoactive substances, tobacco and gambling
Drugs and medicines
Tobacco and electronic cigarettes
Back
Back
Laboratories and testing services
Infectious diseases
Infectious diseases
Respiratory infectious diseases
Respiratory infectious diseases
Données des virus respiratoires
COVID-19 (coronavirus)
Back
Prevention and control of healthcare-associated infections
Prevention and control of healthcare-associated infections
Nosocomial infections
Medical Device Reprocessing
Back
Travel-health
Travel-health
Health tips for travellers
Back
Zoonoses and emerging diseases
Zoonoses and emerging diseases
Diseases transmitted by ticks
Back
Back
Occupational health
Occupational health
Work-related respiratory diseases
Work-related respiratory diseases
Asbestos
Back
Psychosocial risks in the workplace
Psychosocial risks in the workplace
Let's get started
Back
Back
Indigenous Health
Indigenous Health
Research Monitoring
Research Monitoring
Methodology for Indigenous Health Research Monitoring
Back
Nunavik Inuit Health Survey 2004
Back
Environmental health and toxicology
Environmental health and toxicology
Water, food, soil and products
Water, food, soil and products
Per- and polyfluoroalkyl substances (PFAS)
Back
Air quality, environmental noise and non-ionizing radiation
Air quality, environmental noise and non-ionizing radiation
Air quality
Back
Surveillance, skills development, and evaluation approaches in environmental health
Surveillance, skills development, and evaluation approaches in environmental health
Post-Disaster Mental Health Impacts Surveillance Toolkit
Back
Back
Safety, violence and injury prevention
Safety, violence and injury prevention
Community safety promotion
Community safety promotion
Methods and tools
Back
Prevention of interpersonal violence
Prevention of interpersonal violence
Sexual Violence
Rapport québécois sur la violence et la santé
Back
Back
Exit
Back
Services
Services
Centre de toxicologie du Québec
Centre de toxicologie du Québec
About the CTQ
About the CTQ
Contact us
Back
Services
Services
Test catalog
Analysis request forms
Shipping samples
PayPal Bill Payment
Back
External quality assessment schemes
External quality assessment schemes
AMAP: AMAP Ring Test for Persistent Organic Pollutants in Human Serum
Creatinine: Interlaboratory Comparison Program for Measurement of Serum Creatinine
OSEQAS: External Quality Assessment Scheme for Organic Substances in Urine
PCI: Interlaboratory Comparison Program for Metals in Biological Matrices
QMEQAS: Quebec Multielement External Quality Assessment Scheme
Back
Back
Infectious diseases
Infectious diseases
Blood-Borne Infection Risk Assessment Unit
Blood-Borne Infection Risk Assessment Unit
Risk Assessment Process
Rights and Responsibilities
Back
Back
Exit
Back
Publications
Publications
Publications
Subscribe to INSPQ's mailing lists
Exit
Back
Surveys
Surveys
Respiratory viruses survey
Respiratory viruses survey
Complete the survey (period May 18 to 24, 2025)
Back
Exit
Back
Search
Search by keywords
Search by keywords
Geneviève Deceuninck
Publications
INSPQ
2025
Stratégie de prévention des infections pneumococciques au Québec avec l’introduction des nouveaux vaccins conjugués
2024
Programme de surveillance du pneumocoque : rapport 2021-2022
Vaccination contre le méningocoque de sérogroupe Y au Québec dans un contexte d’incidence accrue des infections invasives
2022
Utilisation des vaccins conjugués contre les pneumocoques pour les patients immunodéprimés
Estimation de l’incidence cumulative d’infection COVID-19 dans la population en se basant sur celle observée chez les travailleurs de la santé entre le 27 février 2022 et le 28 mai 2022
Programme de surveillance du pneumocoque : rapport 2020
COVID-19 : Transmission extérieure
2021
Programme de surveillance du pneumocoque : rapport 2019
Efficacité d’une dose de vaccin contre la COVID-19 chez les personnes de 60 ans et plus vivant dans la communauté au Québec
Impact de la première dose de vaccin contre la COVID-19 dans les CHSLD et les RPA
2020
Portrait de la maladie à coronavirus 2019 (COVID-19) chez les résidents des centres d’hébergement et de soins de longue durée (CHSLD) du Québec
Portrait de la COVID-19 parmi les enfants du Québec du 23 février au 11 juillet 2020
Programme de surveillance du pneumocoque : rapport 2018
2019
Impact épidémiologique de la campagne de vaccination contre le méningocoque de sérogroupe B dans la région du Saguenay–Lac-Saint-Jean, en 2014 : rapport au 30 juin 2018
2018
Impact du programme d’immunisation contre les maladies invasives à pneumocoque au Québec, 2010-2014
2017
Avis sur l’utilisation des vaccins pneumococciques conjugués 13-valent (VPC-13) et polysaccharidiques (VPP-23) pour la prévention des infections invasives à pneumocoque et les pneumonies d’origine communautaire chez les personnes âgées de 65 ans et plus
2015
Impact épidémiologique de la campagne de vaccination contre le méningocoque de sérogroupe B dans la région du Saguenay–Lac-Saint-Jean, en 2014 : rapport au 31 décembre 2014
2013
Risque de survenue du syndrome de Guillain-Barré à la suite de l'administration de vaccins pandémiques A(H1N1) durant l'automne 2009 dans la province de Québec
2010
Enquête sur la couverture vaccinale des enfants de 1 an et 2 ans au Québec en 2008
2008
Impact du programme d'immunisation par le vaccin pneumococcique conjugué heptavalent (VPC-7), au Québec, Canada
Articles
2024
Effectiveness of the ten- and thirteen-valent pneumococcal conjugate vaccines to prevent serotype 19A invasive pneumococcal disease in Quebec, Canada. A Canadian immunization research network (CIRN) study
Temporal variations in the serogroup distribution of invasive meningococcal disease in Quebec, Canada, due to emerging unique clade of serogroup Y strain belonging to the Sequence Type-23 clonal complex
2022
Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA-Vaccinated and Nonvaccinated Individuals in Quebec, Canada
Chronic diseases and compliance with provincial guidelines for outpatient antibiotic prescription in cases of otitis media and respiratory infections: a population-based study of linked data in Quebec, Canada, 2010-2017
Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study
Impact of the first vaccine dose on COVID-19 and its complications in long-term care facilities and private residences for seniors in Québec, Canada
Government of Quebec
Government of Quebec
